We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF
ARKG

311 hedge funds and large institutions have $715M invested in ARK Genomic Revolution ETF in 2022 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 77 increasing their positions, 116 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more call options, than puts

Call options by funds: $102M | Put options by funds: $74.8M

14% more capital invested

Capital invested by funds: $628M → $715M (+$87M)

3.16% more ownership

Funds ownership: 26.68% → 29.84% (+3.2%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less funds holding

Funds holding: 333 → 311 (-22)

34% less repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 116

39% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 44

Holders
311
Holders Change
-22
Holders Change %
-6.61%
% of All Funds
5.36%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
27
Increased
77
Reduced
116
Closed
44
Calls
$102M
Puts
$74.8M
Net Calls
+$26.9M
Net Calls Change
+$38M

Top Buyers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$59.3M
2
Morgan Stanley
Morgan Stanley
New York
+$56.7M
3
Goldman Sachs
Goldman Sachs
New York
+$25.5M
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
+$9.29M
5
Citigroup
Citigroup
New York
+$7.64M

Top Sellers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
-$23.6M
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$17.2M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$7.83M
4
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$6.26M
5
Bank of America
Bank of America
North Carolina
-$6.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
KFS
276
Kelly Financial Services
Massachusetts
$2.17K – – –
MIM
277
Macroview Investment Management
Maryland
$2K -$1.25K -34 -35%
AWM
278
Atticus Wealth Management
Florida
$2K – – –
BHWM
279
Bay Harbor Wealth Management
Maryland
$2K – – –
BWM
280
Baystate Wealth Management
Massachusetts
$2K – – –
CT
281
Cambridge Trust
Massachusetts
$2K – – –
CWM
282
CarsonAllaria Wealth Management
Illinois
$2K – – –
EWA
283
EverSource Wealth Advisors
Alabama
$2K – – –
RG
284
Retirement Group
California
$2K – – –
RDFA
285
Ritter Daniher Financial Advisory
Ohio
$2K – – –
WA
286
Win Advisors
Florida
$2K – – –
SPWG
287
Sage Private Wealth Group
Illinois
$2K +$1.84K +50 New
BWP
288
Baldwin Wealth Partners
Massachusetts
$1K – – –
CMP
289
Coston McIsaac & Partners
Maine
$1K – – –
C
290
Covestor
United Kingdom
$1K – – –
FWM
291
Focused Wealth Management
New York
$1K – – –
HI
292
Hudock Inc
Pennsylvania
$1K – – –
JWM
293
Janiczek Wealth Management
Colorado
$1K – – –
KFI
294
Key Financial Inc
Pennsylvania
$1K – – –
MCM
295
Manchester Capital Management
Vermont
$1K – – –
WBC
296
West Branch Capital
Massachusetts
$1K – – –
BHWM
297
Beaird Harris Wealth Management
Texas
$1K +$147 +4 +11%
EC
298
EdgeRock Capital
Colorado
$1K +$734 +20 New
FFA
299
Fairfield Financial Advisors
Massachusetts
$986 – – –
BC
300
Barrett & Company
Rhode Island
$706 +$918 +25 New
10 11
12
13 14

ARKG Hedge Fund Activity: Q3 2022 in Review

311 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q3 2022, worth a combined $715M — up 14% from $628M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of ARKG and 27 opened new positions — a net loss of 17 holders — while 116 trimmed existing stakes and 77 added.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $59.3M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $23.6M sold.

  • 311 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q3 2022, down from 333 in Q2 2022.
  • Funds reported $715M of ARK Genomic Revolution ETF stock for Q3 2022, up 14% quarter-over-quarter.
  • 27 funds opened new ARK Genomic Revolution ETF positions in Q3 2022 and 44 closed out, a net change of -17 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q3 2022 was BNP Paribas Financial Markets, an estimated $59.3M added.
  • The largest ARK Genomic Revolution ETF seller in Q3 2022 was Avidity Partners Management, an estimated $23.6M sold.

Based on aggregated 13F filings for Q3 2022.